Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (885)

2024

  1. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

    Infectious Diseases

  2. COVID-19: On the threshold of the fifth year. The situation in Spain

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

  3. Economic Burden of Clostridioides difficile Infection in European Countries

    Advances in experimental medicine and biology, Vol. 1435, pp. 1-12

  4. Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals

    Nutrients, Vol. 16, Núm. 6

  5. Infectious complications following major heart surgery from the day of the surgery to hospital discharge

    BMC Infectious Diseases, Vol. 24, Núm. 1

  6. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

  7. Unresolved issues in the diagnosis of catheter related candidemia: A position paper

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 1-16

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  3. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  4. Comparative study of the etiology of nosocomial bacteremic pneumonia in ventilated and non-ventilated patients: a 10-year experience in an institution

    Microbiology spectrum, Vol. 11, Núm. 6, pp. e0151723

  5. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  6. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 45-51

  7. How to manage skin and soft-tissue infections in the emergency department

    Current Opinion in Infectious Diseases, Vol. 36, Núm. 2, pp. 81-88

  8. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  9. Insights for COVID-19 in 2023

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 114-124

  10. Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  11. Nosocomial Infections in Adult Patients Supported by Extracorporeal Membrane Oxygenation in a Cardiac Intensive Care Unit

    Microorganisms, Vol. 11, Núm. 4

  12. Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging Assessments in a Mouse Model of Implant-Related Bone and Joint Staphylococcus aureus Infection

    Microbiology spectrum, Vol. 11, Núm. 3, pp. e0454022

  13. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

    Open Forum Infectious Diseases, Vol. 10, Núm. 2